Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Completed

Conditions studied: Brain and Central Nervous System Tumors

In brief

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This laboratory study is looking at tissue samples from patients with glioblastoma multiforme to identify biomarkers that may improve the selection of patients for epidermal growth factor receptor inhibitor therapies.

Key facts

Study ID

NCT00897663

Run by

Alliance for Clinical Trials in Oncology

People needed

56

Starts

2006-11-01

Expected to finish

2018-01-01

Last updated by the study team

2018-01-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Mayo Clinic Scottsdale — Scottsdale, Arizona, United States
• Mayo Clinic - Jacksonville — Jacksonville, Florida, United States
• Siouxland Hematology-Oncology Associates, LLP — Sioux City, Iowa, United States
• Mercy Medical Center - Sioux City — Sioux City, Iowa, United States
• St. Luke's Regional Medical Center — Sioux City, Iowa, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• Medcenter One Hospital Cancer Care Center — Bismarck, North Dakota, United States
• Mid Dakota Clinic, PC — Bismarck, North Dakota, United States
• St. Alexius Medical Center Cancer Center — Bismarck, North Dakota, United States
• Rapid City Regional Hospital — Rapid City, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.